Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ØJENHOSPITALET DANMARK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2020/6 2020 2021/6 2021 2022/6 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   4.3% 1.7% 1.8% 1.5% 3.2% 1.5% 11.4% 11.2%   Credit score (0-100)   49 73 70 76 55 76 21 22   Credit rating   BBB A A A BBB A BB BB   Credit limit (kDKK)   0.0 7.2 4.3 32.4 0.0 44.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2020/6 2020 2021/6 2021 2022/6 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   17,745 11,279 16,244 10,809 24,081 23,530 0.0 0.0   EBITDA   348 1,413 4,014 3,073 6,695 5,654 0.0 0.0   EBIT   -866 307 2,982 3,016 6,367 5,155 0.0 0.0   Pre-tax profit (PTP)   -881.9 508.6 2,940.0 2,969.0 6,422.0 5,211.9 0.0 0.0   Net earnings   -881.9 361.0 2,276.0 2,321.0 4,972.0 4,018.7 0.0 0.0   Pre-tax profit without non-rec. items   -882 509 2,940 2,969 6,422 5,212 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2020/6 2020 2021/6 2021 2022/6 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   5,382 4,991 4,674 5,179 5,503 7,869 0.0 0.0   Shareholders equity total   2,480 2,723 4,998 3,219 4,864 6,483 721 721   Interest-bearing liabilities   6,350 6,202 155 3,585 306 1,272 0.0 0.0   Balance sheet total (assets)   10,340 11,655 7,747 11,248 10,852 12,863 721 721   Net Debt   5,510 4,652 -1,001 -937 -1,499 332 -721 -721     See the entire balance sheet 1000.0 Volume  2019 2020/6 2020 2021/6 2021 2022/6 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   17,745 11,279 16,244 10,809 24,081 23,530 0.0 0.0   Gross profit growth   13.4% -36.4% 44.0% -33.5% 122.8% -2.3% -100.0% 0.0%   Employees   0 14 14 16 17 18 0 0   Employee growth %   0.0% 0.0% 0.0% 14.3% 6.3% 5.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   10,340 11,655 7,747 11,248 10,852 12,863 721 721   Balance sheet change%   0.6% 12.7% -33.5% 45.2% -3.5% 18.5% -94.4% 0.0%   Added value   348.3 1,412.5 4,014.0 3,073.0 6,424.0 5,654.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,827 -9,464 1,160 469 -28 1,963 -4,910 -3,062   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2019 2020/6 2020 2021/6 2021 2022/6 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -4.9% 2.7% 18.4% 27.9% 26.4% 21.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -8.3% 4.8% 30.7% 31.8% 58.3% 44.2% 0.0% 0.0%   ROI %   -9.1% 5.8% 36.8% 42.0% 91.5% 69.1% 0.0% 0.0%   ROE %   -30.2% 13.9% 59.0% 56.5% 123.0% 70.8% 0.0% 0.0%   1000.0 Solidity  2019 2020/6 2020 2021/6 2021 2022/6 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   24.0% 23.4% 64.5% 28.6% 44.8% 50.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1,582.1% 329.3% -24.9% -30.5% -22.4% 5.9% 0.0% 0.0%   Gearing %   256.1% 227.8% 3.1% 111.4% 6.3% 19.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.4% 0.4% 1.3% 2.5% 0.9% 4.3% 0.0% 0.0%   1000.0 Liquidity  2019 2020/6 2020 2021/6 2021 2022/6 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.4 0.7 1.8 0.8 1.0 0.8 0.0 0.0   Current Ratio   0.4 0.7 1.8 0.8 1.0 0.8 0.0 0.0   Cash and cash equivalent   839.4 1,549.6 1,156.0 4,522.0 1,805.0 940.2 0.0 0.0   1000.0 Capital use efficiency  2019 2020/6 2020 2021/6 2021 2022/6 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -4,811.7 -2,723.9 1,153.0 -1,007.0 -121.0 -800.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2020/6 2020 2021/6 2021 2022/6 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 101 287 192 378 314 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 101 287 192 394 314 0 0   EBIT / employee   0 22 213 189 375 286 0 0   Net earnings / employee   0 26 163 145 292 223 0 0